| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 10/28/2004 | US20040213786 using anti interferon gamma inducing factor antibody; inducing protective immunity against the diseases; humanized monoclonal antibody |
| 10/28/2004 | US20040213785 Stabilizedpreparations containing antibody |
| 10/28/2004 | US20040213784 bone marrow transplant (BMT), peripheral blood stem cell (PBSC); use of anti-CD20 monoclonal antibody (RITUXAN) as a purging agent during treatment of B-cell-related malignancies, e.g., B-cell lymphomas or leukemias; enhance engraftment and/or prevent disease relapse |
| 10/28/2004 | US20040213783 modulation of CD200 or CD200R using a polyclonal antibody; a monoclonal antibody; a humanized antibody; an Fv, Fab, or F(ab')2 fragment; a blocking antibody; or a peptide mimetic of an antibody; autoimmune disorders |
| 10/28/2004 | US20040213779 Methods for treating viral infections using immunoconjugates to aminophospholipids |
| 10/28/2004 | US20040213763 administering intravenously to the mammal an adenoviral vector comprising a DNA sequence encoding a leptin operably linked to a promoter and expressing the DNA sequence, for treating obesity in a mammal having a deficiency in functional leptin |
| 10/28/2004 | US20040213761 administering to a patient an effective amount of an agonist or antagonist of IL-23, for wound healing |
| 10/28/2004 | US20040213760 Composition and method for delivery of biologically-active factors |
| 10/28/2004 | CA2817265A1 Recombinant il-9 antibodies and uses thereof |
| 10/28/2004 | CA2522985A1 Means and methods for diagnosing and treating affective disorders |
| 10/28/2004 | CA2522331A1 Alteration of fcrn binding affinities or serum half-lives of antibodies by mutagenesis |
| 10/28/2004 | CA2522207A1 Methods for ex vivo hybridoma-free production of polyclonal and monoclonal antibodies and generation of immortalized cell populations |
| 10/28/2004 | CA2522082A1 Epha2, hypoproliferative cell disorders and epithelial and endothelial reconstitution |
| 10/28/2004 | CA2522076A1 Method for identifying modulators of g protein coupled receptor signaling |
| 10/28/2004 | CA2522007A1 Methods of preventing or treating respiratory conditions |
| 10/28/2004 | CA2521826A1 Recombinant il-9 antibodies and uses thereof |
| 10/28/2004 | CA2521594A1 Epha2 and non-neoplastic hyperproliferative cell disorders |
| 10/28/2004 | CA2521082A1 Surface receptor complexes as biomarkers |
| 10/28/2004 | CA2521077A1 Erbb surface receptor complexes as biomarkers |
| 10/28/2004 | CA2520945A1 Assessing neuronal damage from blood samples |
| 10/28/2004 | CA2519870A1 Use of rituximab intravenous compositions to treat rheumatoid arthristis |
| 10/28/2004 | CA2517926A1 Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells |
| 10/28/2004 | CA2511946A1 Purification of polypeptides |
| 10/27/2004 | EP1471147A2 Method of making a recombinant molecule for the expression of HPV-16 L1 protein |
| 10/27/2004 | EP1471142A1 Heterodimeric receptor libraries using phagemids |
| 10/27/2004 | EP1471075A2 Human nucleic acid sequences expressed in pancreatic carcinomas |
| 10/27/2004 | EP1470825A1 Reagents for detecting efavirenz |
| 10/27/2004 | EP1470420A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 10/27/2004 | EP1470237A2 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria |
| 10/27/2004 | EP1470223A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 10/27/2004 | EP1470222A2 Transgenic animal comprising intracellular immunoglobins for xenotransplantation |
| 10/27/2004 | EP1470161A1 Bispecific antibody dna constructs for intramuscular administration |
| 10/27/2004 | EP1470160A2 Immune globulin formulations for the treatment and prevention of an orthopoxvirus infection |
| 10/27/2004 | EP1470159A2 Antibody to latent membrane proteins and uses thereof |
| 10/27/2004 | EP1470154A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 10/27/2004 | EP1470146A2 Antibodies against the muc18 antigen |
| 10/27/2004 | EP1469883A2 Compositions and methods for regulating lymphocyte activation |
| 10/27/2004 | EP1469882A2 Treatment of ms with goat serum |
| 10/27/2004 | EP1469881A2 Vaccine adjuvant based on a cd40 ligand |
| 10/27/2004 | EP1469879A1 Diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders |
| 10/27/2004 | EP1469878A2 Fgfr agonists |
| 10/27/2004 | EP1469877A2 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies |
| 10/27/2004 | EP1469869A2 Peptide useful in immunomodulation |
| 10/27/2004 | EP1469769A2 Novel compositions and methods for cancer |
| 10/27/2004 | EP1169057B1 Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein |
| 10/27/2004 | EP1107773A4 Method for detection of legionella bacteria employing purified antigen-specific antibodies |
| 10/27/2004 | EP1079860B1 Nicotine immunogen |
| 10/27/2004 | EP0807125B1 Monoclonal antibodies anti-cd6 for the treatment and diagnosis of psoriasis |
| 10/27/2004 | EP0721015B1 Monoclonal antibody that induces apoptosis |
| 10/27/2004 | EP0717108B1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins |
| 10/27/2004 | CN1541335A EPF receptor assays, compounds and therapeutic compsns. |
| 10/27/2004 | CN1541266A FCE fusion proteins for treatment of allergy and asthma |
| 10/27/2004 | CN1541265A Identification of DNA variant associated with adult type hypolactasia |
| 10/27/2004 | CN1541226A Antibodes specific for CD44V6 |
| 10/27/2004 | CN1541225A Humanized antibodies that recognize beta amyloid peptide |
| 10/27/2004 | CN1541224A Antagonistic anti-hTNFSF13b Human antibodies |
| 10/27/2004 | CN1541222A Antibodies to non-functional P 2 Chi 7 receptor diagnosis and treatment of cancers and other conditions |
| 10/27/2004 | CN1541110A Methods for sterilizing prepns of monoclonal immunoglobulins |
| 10/27/2004 | CN1541109A Inhibitors of HER3 activity |
| 10/27/2004 | CN1539970A Heterophil neutral leucocyte factor alpha |
| 10/27/2004 | CN1539969A Gene of prawn and coded polypeptide |
| 10/27/2004 | CN1539849A Polypeptides encoded by haman lipase-like gene and compsns, and metods of utilizing same |
| 10/27/2004 | CN1173037C Single-chain bifunctional glycoprotein hormones |
| 10/27/2004 | CN1173034C TSA 305 gene |
| 10/27/2004 | CN1172954C High-expression gene of liver cancer, proteni coded by it and its application |
| 10/27/2004 | CN1172717C Method for treating AIDS and its preparing method |
| 10/26/2004 | US6809189 Apoptin-associating protein |
| 10/26/2004 | US6809185 Created by heterodimerization of immunoglobulin domains; have two or more antigen binding parts; for diagnosis/treatment of human diseases |
| 10/26/2004 | US6809184 Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use |
| 10/26/2004 | US6809179 Immunogenic peptides used in immunotherapy of cancers/tumors; immunostimulants |
| 10/26/2004 | US6809178 Polypeptide for use in the treatment of addison's disease |
| 10/26/2004 | US6809175 Cadherin derived growth factor and its use |
| 10/26/2004 | US6809078 Nucleotide sequences coding polypeptide use in the generation of insect resistant plants; biological pest control |
| 10/26/2004 | US6808912 For diagnosis/therapy of inflammation, cancer, arteriosclerosis, and psoriasis |
| 10/26/2004 | US6808902 Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
| 10/26/2004 | US6808901 Production of chimeric antibodies |
| 10/26/2004 | US6808894 Methods for generating genetically altered antibody producing cell lines with improved antibody characteristics |
| 10/26/2004 | US6808891 Modulators of the function of FAS/APO1 receptors |
| 10/26/2004 | US6808712 Imunogenic a beta fragment linked to immunoglobulin carrier to form conjugate; adjuvant comprising antibodies to a beta fragment enhances immune response; alzheimer*s disease treatment |
| 10/26/2004 | US6808710 Contacting cell expressing pd-1 with binding agent; genetic transduction of negative signal |
| 10/26/2004 | US6808709 Immunoglobulins containing protection proteins and their use |
| 10/26/2004 | CA2263888C Methods and compositions for the detection of cervical cancer |
| 10/26/2004 | CA2177616C Preparation and use of immunoconjugates |
| 10/26/2004 | CA1341461C T helper cell growth factor |
| 10/22/2004 | CA2465017A1 Reagents for detecting efavirenz |
| 10/21/2004 | WO2004090544A2 Detection, characterization and treatment of viral infection and methods thereof |
| 10/21/2004 | WO2004090157A1 The use of pde4d in the screening for medicaments against atherosclerosis |
| 10/21/2004 | WO2004090139A1 Method for the construction of randomized gene sequence libraries in cells |
| 10/21/2004 | WO2004090135A2 Cytokine polypeptides and antibodies containing a signal sequence for the attachement of glycosylphosphatidylinositol |
| 10/21/2004 | WO2004090126A2 Phosphodiesterase 10a7 isoforms and methods of use |
| 10/21/2004 | WO2004090110A2 Compositions and methods for the control, differentiation and/or manipulation of pluripotent cells through a gamma-secretase signaling pathway |
| 10/21/2004 | WO2004090109A2 Ccn3 compositions and methods |
| 10/21/2004 | WO2004089990A1 New monoclonal antibody capable of binding integrin alpha 10 beta 1 |
| 10/21/2004 | WO2004089989A1 Cancerous disease modifying antibodies |
| 10/21/2004 | WO2004089988A2 Inhibitors of integrin alpha5beta1 and their use for the control of tissue granulation |
| 10/21/2004 | WO2004089984A1 Antigen recognizing antibody |
| 10/21/2004 | WO2004089386A1 Antiobestic agent using hen’s egg antibody against digestive enzymes |
| 10/21/2004 | WO2004089284A2 Targets for tumor growth inhibition |
| 10/21/2004 | WO2004076620A9 Human antibodies specific for interleukin 15 (il-15) |
| 10/21/2004 | WO2004052932A3 Antibody (“11c7”) anti nogo a and its pharmaceutical use |